Real-world evidence in Alzheimer's disease: The ROADMAP Data Cube
Olin Janssen, Stephanie J.B. Vos, Glòria García-Negredo, Claire Tochel, Anders Gustavsson, Michael Smith, Amanda Ly, Mia Nelson, Helen Baldwin, Catherine Sudlow, Christin Bexelius, Christoph Jindra, Nemanja Vaci, Sarah Bauermeister, John Gallacher, Anna Ponjoan, Carole Dufouil, Josep Garre Olmo, Lars Pedersen, Ingmar Skoog, Antje Hottgenroth, Pieter Jelle Visser, Johan van der Lei, Carlos Diaz
Introduction The ROADMAP project aimed to provide an integrated overview of European real-world data on Alzheimer's disease (AD) across the disease spectrum. Methods Metadata were identified from data sources in catalogs of European AD projects. Priority outcomes for different stakeholders were identified through systematic literature review, patient and public consultations, and stakeholder surveys. Results Information about 66 data sources and 13 outcome domains were integrated into a Data Cube. Gap analysis identified cognitive ability, functional ability/independence, behavioral/neuropsychiatric symptoms, treatment, comorbidities, and mortality as the outcomes collected most. Data were most lacking in caregiver-related outcomes. In general, electronic health records covered a broader, less detailed data spectrum than research cohorts. Discussion This integrated real-world AD data overview provides an intuitive visual model that facilitates initial assessment and identification of gaps in relevant outcomes data to inform future prospective data collection and matching of data sources and outcomes against research protocols.